Telesis Bio Stock Working Capital
| TBIODelisted Stock | USD 2.98 0.02 0.67% |
Telesis Bio fundamentals help investors to digest information that contributes to Telesis Bio's financial success or failures. It also enables traders to predict the movement of Telesis Pink Sheet. The fundamental analysis module provides a way to measure Telesis Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Telesis Bio pink sheet.
Telesis |
Telesis Bio Company Working Capital Analysis
Telesis Bio's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Telesis Bio Working Capital | 22.17 M |
Most of Telesis Bio's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Telesis Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Telesis Bio has a Working Capital of 22.17 M. This is 94.79% lower than that of the Health Care Equipment & Supplies sector and 95.88% lower than that of the Health Care industry. The working capital for all United States stocks is 98.5% higher than that of the company.
Telesis Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Telesis Bio's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Telesis Bio could also be used in its relative valuation, which is a method of valuing Telesis Bio by comparing valuation metrics of similar companies.Telesis Bio is currently under evaluation in working capital category among its peers.
Telesis Fundamentals
| Return On Equity | -1.48 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (6.76) % | ||||
| Current Valuation | 61.1 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 37.90 % | ||||
| Shares Owned By Institutions | 32.97 % | ||||
| Number Of Shares Shorted | 29.7 K | ||||
| Price To Earning | 71.32 X | ||||
| Price To Book | 1.11 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 27.51 M | ||||
| Gross Profit | 15.6 M | ||||
| EBITDA | (31.05 M) | ||||
| Net Income | (47.72 M) | ||||
| Cash And Equivalents | 654.75 M | ||||
| Cash Per Share | 8.70 X | ||||
| Total Debt | 34.38 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (11.59) X | ||||
| Cash Flow From Operations | (34.67 M) | ||||
| Short Ratio | 0.42 X | ||||
| Earnings Per Share | (30.42) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 101 | ||||
| Beta | 1.76 | ||||
| Market Capitalization | 5.73 M | ||||
| Total Asset | 70.41 M | ||||
| Retained Earnings | (161.47 M) | ||||
| Working Capital | 22.17 M | ||||
| Current Asset | 3.28 M | ||||
| Current Liabilities | 16.98 M | ||||
| Net Asset | 70.41 M |
About Telesis Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Telesis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telesis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telesis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Telesis Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telesis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will appreciate offsetting losses from the drop in the long position's value.Moving against Telesis Pink Sheet
| 0.66 | ECOR | Electrocore LLC | PairCorr |
| 0.63 | NXL | Nexalin Technology | PairCorr |
| 0.61 | PEN | Penumbra | PairCorr |
| 0.57 | MYO | Myomo Inc | PairCorr |
| 0.56 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to Telesis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telesis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telesis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telesis Bio to buy it.
The correlation of Telesis Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telesis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telesis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telesis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |